Cardiac MRI shows myocarditis less common in athletes recovered from COVID-19 than previously thought

Cardiac MRI has revealed that heart muscle inflammation is not as common in athletes recovered from COVID-19 as previously thought, according to new research published by the American Heart Association.

Vanderbilt University Medical Center researchers compared 59 student-athletes who had the novel virus to a near equal amount of healthy controls. It’s well known that COVID-19 may affect the heart, but this recent finding brings much-needed positive news, the group explained in a letter published by the journal Circulation.

“The degree of myocarditis found by cardiac MRI in Vanderbilt athletes was only 3%, which is really good news," first author Dan Clark, MD, MPH, an instructor of cardiovascular medicine at the university, said in a statement. "Since our first evaluation, we have screened almost double that number and the same findings are holding true.”

Results of the COVID-19 Myocardial Pathology Evaluation in AthleTEs with Cardiac Magnetic Resonance study, or COMPETE CMR, did, however, reveal more scarring in healthy heart muscle than researchers would have hypothesized.

They also reported similarly “disappointing” news, Clark noted. Other screening tests such as blood work, clinical exams, EKG, echocardiograms and additional tests did not help identify athletes with myocarditis and no COVID-19 symptoms. Clark et al. had hoped to only use CMR in special situations.

"Initially, we hoped that the standard screening tests for athletes would be definitive because we wanted something that was widely available and quick," he explained. “All of those traditional screening results would have led us to agree to allow some athletes to participate in a sporting event or practice, while the MRI told a different story,” Clark added.

The team believes that using cardiac MRI to assess athletes may help determine if they’re ready to get back out onto the field.

 

Related COVID-19 Content:

Myocarditis, arrhythmias and more: An ACC update on what cardiologists know about long COVID-19

Athletes with COVID-19 may require heart MRI screening for myocarditis, new data suggest

4 cardiac arrhythmias associated with COVID-19

What we know about COVID-19 and cardiogenic shock

Mild COVID-19 infections not associated with long-term risk of heart damage

The pandemic’s toll: 55 long-term side effects of COVID-19

4 key takeaways from an updated look at vaccine-related myocarditis in the U.S.

Most young people with vaccine-related myocarditis recover quickly

Intrathoracic complications in COVID patients: Incidence, associations and outcomes

Congenital heart disease increases risk of poor COVID-19 outcomes, including death

MRI scans show COVID's 'significant' impact on the brain

Heart complication seen for the first time in a young patient after COVID-19 vaccination

American Heart Association investing $10 million to study the long-term consequences of COVID-19

Cardiologist discusses COVID-19, myocarditis among professional athletes and more

Not so fast: Specialists warn against cardiac imaging for asymptomatic COVID-19 patients

Study shows COVID-19 can infect heart cells—and do serious damage in the process

ACC issues COVID-19 guidance for cardiologists

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.